CAS No. |
180713-37-5 |
中文名称 |
(2E,4E,6Z)-3-甲基-7-(5,5,8,8-四甲基-3-丙氧基-5,6,7,8-四氢萘-2-基)辛-2,4,6-三烯酸 |
英文名称 |
(2E,4E,6Z)-3-Methyl-7-(5,5,8,8-tetramethyl-3-propoxy-5,6,7,8-tetrahydronaphthalen-2-yl)octa-2,4,6-trienoic acid |
别名 |
LGD 100754 | LG 100754 | (2E,4E,6Z)-3-Methyl-7-(5,5,8,8-tetramethyl-3-propoxy-5,6,7,8-tetrahydro-naphthalen-2-yl)-octa-2,4,6-trienoic acid | (2e,4e,6z)-3-Methyl-7-(5,5,8,8-Tetramethyl-3-Propoxy-5,6,7,8-Tetrahydronaphthalen-2-Yl)octa-2,4,6-Trienoic Acid | |
标准英文名 |
(2E,4E,6Z)-3-methyl-7-(5,5,8,8-tetramethyl-3-propoxy-5,6,7,8-tetrahydronaphthalen-2-yl)octa-2,4,6-trienoic acid |
分子式 |
C26H36O3 |
分子量 |
396.57
|
精确分子量 |
396.27
|
SMILES |
C/C(C1=C(OCCC)C=C2C(C)(C)CCC(C)(C)C2=C1)=C/C=C/C(C)=C/C(O)=O |
标准SMILES |
CCCOC1C=C2C(=CC=1/C(/C)=C\C=C\C(\C)=C\C(O)=O)C(C)(C)CCC2(C)C |
用途 |
LG100754 (UVI2112) is a modulator of RXR dimers, acting as an antagonist of RXR:RXR homodimers and an agonist of RXR:PPARα and RXR:PPARγ heterodimers; it functions as an insulin sensitizer via RXR; it is a selective activator of endogenous RXR heterodimers; it improves TNFα-mediated insulin resistance in mature adipocytes; it acts as a bona fide activator of endogenous RXR:PPARγ heterodimers and a regulator of insulin-dependent signaling pathways; in vivo, it completely blocks the increase in glucose levels at 100 mg/kg, demonstrating its ability to improve insulin resistance. |
InChIKey |
HNODNXQAYXJFMQ-LQUSFLDPSA-N |